Auxiliary liver transplant study
This study looks at how well auxiliary liver transplants work and what affects long-term outcomes. It compares different types of liver transplants to help doctors understand which approach is best for certain patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an auxiliary (partial) liver transplant or a living donor liver transplant.
- Your medical records and follow-up information are complete.
- You did not need a second (repeat) liver transplant.
- You did not receive any other organ transplant at the same time.
- You have not been lost to follow-up after your transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is creating a database of people with severe liver problems or who have had a liver transplant. The goal is to learn more about these conditions and improve care.
This study looks at living donor liver transplant care and follows patients for about 3 years to see how they do over time. If you had (or are scheduled for) a living donor liver transplant and can be followed long-term, this trial may be able to collect your outcomes.
This study looks at two blood markers (AFP and PIVKA-II) to see if they can help predict outcomes for people getting a liver transplant for liver cancer. It aims to find better ways to guide care after transplant.
This study compares how different surgical techniques for removing and preparing donor livers affect patient outcomes after transplantation. You would be tracked to see how well your transplanted liver works depending on the method used to obtain it.
This study follows liver transplant recipients and living donors over time to track their health outcomes. It aims to understand their recovery and long-term wellbeing.
This study looks at when liver transplant is offered and what outcomes happen in people with cirrhosis who have severe “acute-on-chronic” worsening. It may help doctors decide which patients benefit most from transplant and improve care after listing or not listing.
Hear when a new Liver Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.